Target INR for Mechanical Prosthetic Valves
For mechanical mitral valves, target an INR of 3.0 (acceptable range 2.5–3.5) plus low-dose aspirin 75–100 mg daily; for mechanical aortic valves without additional risk factors, target an INR of 2.5 (range 2.0–3.0). 1
Mechanical Mitral Valve Position
The target INR is 3.0 with an acceptable range of 2.5–3.5 as recommended by both the American College of Cardiology and American College of Chest Physicians. 1
Rationale for Higher INR Target
Mechanical mitral prostheses carry a markedly higher annual thromboembolic incidence (approximately 0.9%) compared to mechanical aortic prostheses (approximately 0.5%), necessitating more intensive anticoagulation. 1
The mitral valve's distinct hemodynamic and flow characteristics render its mechanical prostheses intrinsically more thrombogenic than aortic counterparts. 1
Observational data from Cannegieter's analysis demonstrated that for mitral prostheses, an INR target of 3.0–3.9 reduced thromboembolic events more effectively than a target of 2.0–2.9. 1
Mandatory Aspirin Addition
Add low-dose aspirin 75–100 mg daily to warfarin therapy for all patients with mechanical mitral valves. 1
Combined warfarin plus aspirin therapy lowers mortality (relative risk 0.58,95% CI 0.40–0.86) and thromboembolism (RR 0.42,95% CI 0.21–0.81) compared with warfarin alone. 1
This combination modestly raises major hemorrhage risk (RR 1.44,95% CI 1.0–2.08), but the net benefit on survival and embolic protection outweighs bleeding concerns. 1
Mechanical Aortic Valve Position
For low-risk patients with bileaflet mechanical aortic valves, target an INR of 2.5 (range 2.0–3.0). 2
Risk Stratification for Aortic Valves
Low-risk patients (no additional thromboembolic risk factors) with modern bileaflet aortic valves should maintain INR 2.0–3.0. 3, 4
High-risk patients with any of the following factors require a higher INR target of 2.5–3.5: 1, 2
- Atrial fibrillation
- Prior thromboembolism
- Hypercoagulable state
- Severe left ventricular dysfunction (LVEF <30%)
- Older-generation valve designs (ball-cage or tilting-disc)
- Multiple mechanical valves
Special Consideration for On-X Valves
For On-X aortic valves specifically, after the first 3 months post-implantation, the INR goal can be lowered to 1.5–2.5 with low-dose aspirin in both low- and high-risk patients. 4, 5
During the first 3 months after On-X valve implantation, maintain INR 2.0–3.0. 4
Monitoring and Practical Considerations
Patients targeting INR 3.0–4.5 remain within therapeutic range only 44.5% of the time, whereas those targeting 2.0–3.5 achieve therapeutic range 74.5% of the time, indicating the importance of realistic target selection. 1
The recommended target of 3.0 (range 2.5–3.5) for mitral valves represents a reasonable compromise between efficacy and achievability. 1
Maintain consistent INR monitoring with a specific target rather than a range to reduce fluctuations and prevent thromboembolic events. 2
Management of Breakthrough Thromboembolism
- If thromboembolism occurs despite therapeutic INR in a patient with a mechanical mitral valve, increase the INR goal from 3.0 (range 2.5–3.5) to 4.0 (range 3.5–4.0), and ensure aspirin 75–100 mg daily is added if not already prescribed. 1
Critical Pitfalls to Avoid
Never use prophylactic-dose anticoagulation for mechanical valves—therapeutic dosing is mandatory. 6
Avoid high-dose vitamin K for routine reversal of excessive anticoagulation, as it may create a hypercoagulable condition and complicate re-anticoagulation. 6, 3
Do not target INR ≥5, as excessive anticoagulation increases bleeding risk without additional thromboembolic protection. 2
When INR falls below therapeutic range, the risk of thromboembolism increases significantly, with odds of valve thrombosis increasing approximately 9-fold. 2